Course

Impact of the COVID-19 Pandemic on HIV and HCV Screening and Lessons Learned for 2022

Details

Published Date: 08/23/2022

Expiration Date: 06/14/2025

CE Credit: CME:1

Presenter(s)

Martin Hoenigl,MD

Martin Hoenigl obtained his venia docendi in internal medicine in 2012 and is author to 185 pub med listed publications in the field of infectious diseases. His research currently focuses on acute HIV infection and HIV prevention, and also Clinical Mycology. Dr. Hoenigl received the Researcher of the Year award (2011) at the Medical University of Graz, and the Research Promotion award (2014) from the German Speaking Mycological Society.

Learning Objectives

Know that HIV screening and linkage to care rates dropped significantly during the early phases of the pandemic, and that EMR driven automated emergency department HIV screening programs play a significant role in keeping up HIV screening during this public health emergency.
Understand the dynamics of HCV testing and treatment initiations during COVID-19, with HCV treatment rates failing to rebound.
Appreciate the important role of community-based programs for no-cost HIV and STI testing and treatment services and learn how these programs can be optimized to serve our clients needs.

Continuing Education Credit Information

Learn more and Enroll